Skip to main content
. 2016 May 18;14:150. doi: 10.1186/s12957-016-0900-y

Fig. 2.

Fig. 2

Osteosarcoma patients with low miR-452 expression had a significantly shorter overall survival than those with high miR-452 expression (P < 0.001, log-rank test)